Europe Protein Chip Market is segmented By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Antibody Characterization), By End-User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceuticals & Biotechnological Companies), and By Country (UK, France, Spain, Germany, Italy, and Rest of Europe) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Report Overview
The Europe Protein Chip Market is expected to grow at a CAGR of 18.16% during the forecast period 2023-2030.
Protein microarrays, also known as protein chips, are high-density parallel assay systems containing small amounts of proteins. Protein chips play an important function in diagnostics. With the help of these chips, healthcare providers can check the level of infection for a particular disease or disorder.
Protein chips have been extensively employed in healthcare and biological industries to conduct fundamental research. Furthermore, these chips have been used in drug development research initiatives including contagious and lethal disorders. Protein chips are made comprised of a support surface, such as a glass slide or microtitre plate, that aids in the capture of protein in use, and these molecules are then labelled and assembled in a dye of a certain colour and added to the array. Any interaction between them is then signalled and recorded for future experimentation.
Market Scope
|
Metrics |
Details |
|
CAGR |
18.16% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Technology, Application, and End User |
|
Countries Covered |
UK, France, Spain, Germany, Italy, and Rest of Europe |
|
Largest Country |
Germany |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Drivers
Protein chips have been more popular in recent years due to their advanced technology. This technique is used to monitor protein interactions and activities on a wide scale and establish their function. The European protein chip market is predicted to develop at a high CAGR during the forecast period, due to the increasing burden of chronic illness, proteomic and genomic applications, and the rising need for cutting-edge diagnostic technologies.
According to the Cancer Atlas, in Europe in 2019, there were around 3.96 million new cancer diagnoses and roughly 1.97 million deaths. Protein chips are one of the ground-breaking techniques with a bright future in cancer proteomics research. All of the aforementioned reasons are projected to fuel expansion in the European protein chip market during the forecast period.
Segmentation Analysis
By technology, the functional protein microarray segment is likely to dominate the market throughout the forecast period, owing to its use in advanced diagnostics. Furthermore, the analytical microarray segment is the market's second biggest stakeholder. Heavy expenditures in research and development initiatives including the usage of microarrays would provide the functional protein microarray segment an extra edge in dominating the market throughout the projected period.
Geographical Shares
Geographically, the Europe protein chip market is segmented into UK, France, Spain, Germany, Italy, and Rest of Europe.
Germany led the European protein chip market due to the region's large number of protein chip laboratories and research centres, changes in lifestyle leading to a rise in chronic illness incidence, and improved R&D for the creation of new medications. High-tech approaches will have a substantial influence on biomedicine, biotechnology, and biological analysis in the next years, providing novel performance prospects such as illness detection, biomarker identification, and a broad variety of biotechnology applications.
The protein chip market in the United Kingdom is expected to grow at a substantial CAGR during the projected period, due to increased investment by industry participants and rising acceptance of protein chips for diagnostic applications in the country.
Keyplayers Companies
The global market players contributing to the Europe protein chip market’s growth include SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
